SPOTLIGHT: FDA can't manage foreign drugmaker inspections

A new report from the Government Accountability Office has concluded that the FDA doesn't have the resources to properly inspect foreign companies that manufacture drugs or drug ingredients. At present, the FDA can only inspect 8 percent of the more than 3,000 foreign companies that ship such items to the U.S., the GAO told Congress this week. Article

Post a comment